Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
Article Information
History
- June 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ana Marcu1,
- Andreas Schlosser2,
- Anne Keupp3,
- Nico Trautwein1,
- Pascal Johann4,5,
- Matthias Wölfl3,
- Johanna Lager3,
- Camelia Monoranu6,
- Juliane Sarah Walz1,7,8,9,
- Lisa M. Henkel3,
- Jürgen Krauß10,
- Martin Ebinger11,
- Martin Schuhmann12,
- Ulrich Thomale13,
- Torsten Pietsch14,
- Erdwine Klinker15,
- Paul G. Schlegel3,
- Florian Oyen16,
- Yair Reisner17,
- Hans-Georg Rammensee1 and
- Matthias Eyrich3,*
- 1Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany
- 2Rudolf-Virchow Zentrum, University of Würzburg, Germany
- 3University Children’s Hospital, University Medical Center Würzburg, Germany
- 4DKFZ Heidelberg, Germany
- 5Swabian Children’s Cancer Center Augsburg, Germany
- 6Department of Neuropathology, Institute for Pathology, University of Würzburg, Germany
- 7Cluster of Excellence iFIT (EXC2180), University of Tübingen, Germany
- 8Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany
- 9Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital of Tübingen, Germany
- 10Department of Neurosurgery, University Medical Center Würzburg, Germany
- 11University Children’s Hospital, University Medical Center Tübingen, Germany
- 12Department of Neurosurgery, University Medical Center Tübingen, Germany
- 13Department of Neurosurgery, Charité, Berlin, Germany
- 14Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Germany
- 15Institute for Transfusion Medicine, University Medical Center Würzburg, Germany
- 16University Children’s Hospital, University Medical Center Hamburg Eppendorf, Germany
- 17Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
- ↵*Corresponding author: Matthias Eyrich, MD, University Children’s Hospital, Pediatric Hematology/Oncology, Josef-Schneider-Straße 2, D- 97080 Würzburg, Tel: +49-931-201-27620, email: eyrich_m{at}ukw.de
Posted June 15, 2021.
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos